- Home
- SLQT vs FULC Comparison
SLQT vs FULC Comparison
Compare SLQT & FULC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLQT
- FULC
- Stock Information
- Founded
- SLQT 1999
- FULC 2015
- Country
- SLQT United States
- FULC United States
- Employees
- SLQT N/A
- FULC N/A
- Industry
- SLQT Specialty Insurers
- FULC Biotechnology: Pharmaceutical Preparations
- Sector
- SLQT Finance
- FULC Health Care
- Exchange
- SLQT Nasdaq
- FULC Nasdaq
- Market Cap
- SLQT 343.7M
- FULC 372.2M
- IPO Year
- SLQT 2020
- FULC 2019
- Fundamental
- Price
- SLQT $2.08
- FULC $7.07
- Analyst Decision
- SLQT Hold
- FULC Buy
- Analyst Count
- SLQT 2
- FULC 8
- Target Price
- SLQT $4.38
- FULC $7.13
- AVG Volume (30 Days)
- SLQT 2.8M
- FULC 395.4K
- Earning Date
- SLQT 11-03-2025
- FULC 11-12-2025
- Dividend Yield
- SLQT N/A
- FULC N/A
- EPS Growth
- SLQT N/A
- FULC N/A
- EPS
- SLQT 0.01
- FULC N/A
- Revenue
- SLQT $1,526,594,000.00
- FULC N/A
- Revenue This Year
- SLQT $13.85
- FULC N/A
- Revenue Next Year
- SLQT $13.64
- FULC N/A
- P/E Ratio
- SLQT $154.53
- FULC N/A
- Revenue Growth
- SLQT 15.50
- FULC 2752.05
- 52 Week Low
- SLQT $1.62
- FULC $2.32
- 52 Week High
- SLQT $6.86
- FULC $8.50
- Technical
- Relative Strength Index (RSI)
- SLQT 47.83
- FULC 53.37
- Support Level
- SLQT $1.91
- FULC $6.35
- Resistance Level
- SLQT $2.18
- FULC $7.87
- Average True Range (ATR)
- SLQT 0.12
- FULC 0.38
- MACD
- SLQT -0.02
- FULC 0.05
- Stochastic Oscillator
- SLQT 25.19
- FULC 47.37
About SLQT SelectQuote Inc.
SelectQuote Inc is a Direct-to-consumer (DTC) distribution platform which facilitates consumers to shop for health, life and auto & home insurance policies online. The company generates its revenues by selling insurance products on behalf of the insurance carrier partners in the form of a commission. It has four reportable segments namely Senior, Healthcare Services, Life, and Auto & Home. It functions through three lines namely, SelectQuote Senior, SelectQuote Life, and SelectQuote Auto & Home.
About FULC Fulcrum Therapeutics Inc.
Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company. The company's programs in clinical development are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystrophy (FSHD) and FTX-6058, a small molecule designed to increase expression of fetal hemoglobin for the treatment of sickle cell disease and other hemoglobinopathies, including beta-thalassemia.